These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 10894443)
1. Effects of glibenclamide, a K(ATP) channel blocker, on warm-up phenomenon in type II diabetic patients with chronic stable angina pectoris. Ovünç K Clin Cardiol; 2000 Jul; 23(7):535-9. PubMed ID: 10894443 [TBL] [Abstract][Full Text] [Related]
2. The effects of glibenclamide, a K(ATP) channel blocker, on the warm-up phenomenon. Ferreira BM; Moffa PJ; Falcão A; Uchida A; Camargo P; Pereyra P; Soares PR; Hueb W; Ramires JA Ann Noninvasive Electrocardiol; 2005 Jul; 10(3):356-62. PubMed ID: 16029388 [TBL] [Abstract][Full Text] [Related]
3. Effects of K(ATP) channel blockade by glibenclamide on the warm-up phenomenon. Tomai F; Danesi A; Ghini AS; Crea F; Perino M; Gaspardone A; Ruggeri G; Chiariello L; Gioffrè PA Eur Heart J; 1999 Feb; 20(3):196-202. PubMed ID: 10082152 [TBL] [Abstract][Full Text] [Related]
4. Effect of a hypoglycemic agent on ischemic preconditioning in patients with type 2 diabetes and stable angina pectoris. Hueb W; Uchida AH; Gersh BJ; Betti RT; Lopes N; Moffa PJ; Ferreira BM; Ramires JA; Wajchenberg BL Coron Artery Dis; 2007 Feb; 18(1):55-9. PubMed ID: 17172931 [TBL] [Abstract][Full Text] [Related]
5. Effects of pharmacological modulation of the ATP-sensitive potassium channels on the development of warm-up angina pectoris. Lindhardt TB; Abedini S; Olesen RM; Haunsø S; Gadsbøll N Cardiology; 2006; 105(1):17-21. PubMed ID: 16166774 [TBL] [Abstract][Full Text] [Related]
6. Attenuation of myocardial ischemia with repeated exercise in subjects with chronic stable angina: relation to myocardial contractility, intensity of exercise and the adenosine triphosphate-sensitive potassium channel. Bogaty P; Kingma JG; Robitaille NM; Plante S; Simard S; Charbonneau L; Dumesnil JG J Am Coll Cardiol; 1998 Nov; 32(6):1665-71. PubMed ID: 9822094 [TBL] [Abstract][Full Text] [Related]
7. 'Warm-up' phenomenon in diabetic patients with stable angina treated with diet or sulfonylureas. Bilinska M; Potocka J; Korzeniowska-Kubacka I; Piotrowicz R Coron Artery Dis; 2007 Sep; 18(6):455-62. PubMed ID: 17700217 [TBL] [Abstract][Full Text] [Related]
8. Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker. Tomai F; Crea F; Gaspardone A; Versaci F; De Paulis R; Penta de Peppo A; Chiariello L; Gioffrè PA Circulation; 1994 Aug; 90(2):700-5. PubMed ID: 8044938 [TBL] [Abstract][Full Text] [Related]
9. [Effects of different sulfonylureas on the warm-up phenomenon in diabetes patients with coronary artery disease]. Zheng M; Li LZ; Jiang ZA; Li LH; Feng YG; Fu XH Zhonghua Yi Xue Za Zhi; 2017 Jan; 97(3):198-202. PubMed ID: 28162170 [No Abstract] [Full Text] [Related]
10. Impairment of myocardial protection in type 2 diabetic patients. Lee TM; Chou TF J Clin Endocrinol Metab; 2003 Feb; 88(2):531-7. PubMed ID: 12574175 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the protective effects of a highly selective ATP-sensitive potassium channel opener and ischemic preconditioning in isolated human atrial muscle. Carr CS; Grover GJ; Pugsley WB; Yellon DM Cardiovasc Drugs Ther; 1997 Jul; 11(3):473-8. PubMed ID: 9310276 [TBL] [Abstract][Full Text] [Related]
12. Myocardial perfusion imaging findings and the role of adenosine in the warm-up angina phenomenon. Bogaty P; Kingma JG; Guimond J; Poirier P; Boyer L; Charbonneau L; Dagenais GR J Am Coll Cardiol; 2001 Feb; 37(2):463-9. PubMed ID: 11216964 [TBL] [Abstract][Full Text] [Related]
13. Microcirculatory effects of KATP channel blockade by sulphonylurea derivatives in humans. Abbink EJ; Wollersheim H; Netten PM; Russel FG; Lutterman JA; Smits P Eur J Clin Invest; 2002 Mar; 32(3):163-71. PubMed ID: 11895467 [TBL] [Abstract][Full Text] [Related]
14. The effect of an angiotensin-converting enzyme inhibitor and a K+(ATP) channel opener on warm up angina. Edwards RJ; Redwood SR; Lambiase PD; Marber MS Eur Heart J; 2005 Mar; 26(6):598-606. PubMed ID: 15618027 [TBL] [Abstract][Full Text] [Related]
15. Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication. Mortensen UM; Nielsen-Kudsk JE; Sondergaard HM; Jakobsen P; Jensen BS; Schmitz O; Nielsen TT Diabet Med; 2006 Mar; 23(3):327-30. PubMed ID: 16492219 [TBL] [Abstract][Full Text] [Related]
16. Blockade of ATP-sensitive K+ channels attenuates preconditioning effect on myocardial metabolism in swine: myocardial metabolism and ATP-sensitive K+ channels. Yokota R; Tanaka M; Yamasaki K; Araki M; Miyamae M; Maeda T; Koga K; Yabuuchi Y; Sasayama S Int J Cardiol; 1998 Dec; 67(3):225-36. PubMed ID: 9894703 [TBL] [Abstract][Full Text] [Related]
17. The K(ATP) channel blocker HMR 1883 does not abolish the benefit of ischemic preconditioning on myocardial infarct mass in anesthetized rabbits. Jung O; Englert HC; Jung W; Gögelein H; Schölkens BA; Busch AE; Linz W Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):445-51. PubMed ID: 10763861 [TBL] [Abstract][Full Text] [Related]
19. Glibenclamide action on myocardial function and arrhythmia incidence in the healthy and diabetic heart. Negroni JA; Lascano EC; del Valle HF Cardiovasc Hematol Agents Med Chem; 2007 Jan; 5(1):43-53. PubMed ID: 17266547 [TBL] [Abstract][Full Text] [Related]